These considerations raised the question of whether cognitive improvements seen in AD mice following central SCD inhibition might be mediated in part by changes in peripheral metabolism, either by modulation of central control of peripheral metabolism or via direct peripheral diffusion of the inhibitor. The gene discussed is SCD; the disease is Alzheimer disease.